Plain-English translation of NCT03685721 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying how genetic variations in a gene called PKLR affect the way red blood cells function in people with sickle cell disease. By collecting blood samples from people with sickle cell disease, people with sickle cell trait, and healthy volunteers, they want to understand why some people have more severe symptoms than others and whether certain genetic variations might protect against sickling or make it worse.
Sickle cell disease happens when hemoglobin (a protein in red blood cells) clumps together and damages cells. Recent research suggests that variations in the PKLR gene might influence how likely this clumping is to happen, but scientists don't yet understand exactly how these genetic differences affect individual patients. This study aims to fill that gap so doctors can better understand and eventually treat the disease.
You likely qualify if…
You likely don't qualify if…
You will visit the research clinic where staff will take a blood sample from your arm and ask you some questions about your health history. The visit is typically a one-time event, though researchers may contact you for follow-up information. No medication is involved — this is a study about understanding your genes and how they affect your blood cells, not testing a new treatment.
AI-generated summary from trial data · Jun 8, 2026 · Not medical advice
United States